BioXcel Therapeutics Inc (NASDAQ: BTAI) kicked off on November 20, 2023, at the price of $4.14, down -7.26% from the previous trading day. During the day, the shares moved up to $4.25 and dropped to $3.73 before settling in for the closing price of $4.13. Over the past 52 weeks, BTAI has traded in a range of $2.23-$34.12.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
While this was happening, its average annual earnings per share was recorded 3.61%. With a float of $20.22 million, this company’s outstanding shares have now reached $28.15 million.
In an organization with 183 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +7.47, operating margin of -42242.93, and the pretax margin is -44246.40.
BioXcel Therapeutics Inc (BTAI) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of BioXcel Therapeutics Inc is 30.94%, while institutional ownership is 35.19%. The most recent insider transaction that took place on Jun 16, was worth 605,501. In this transaction CEO and President of this company sold 30,000 shares at a rate of $20.18, taking the stock ownership to the 39,903 shares. Before that another transaction happened on Jun 15, when Company’s CEO and President sold 30,000 for $21.54, making the entire transaction worth $646,226. This insider now owns 39,903 shares in total.
BioXcel Therapeutics Inc (BTAI) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$1.72 earnings per share (EPS), lower than consensus estimate (set at -$1.3) by -$0.42. This company achieved a net margin of -44201.87 while generating a return on equity of -111.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.61% per share during the next fiscal year.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Trading Performance Indicators
Take a look at BioXcel Therapeutics Inc’s (BTAI) current performance indicators. Last quarter, stock had a quick ratio of 2.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 90.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.36, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -2.06 in one year’s time.
Technical Analysis of BioXcel Therapeutics Inc (BTAI)
Let’s dig in a bit further. During the last 5-days, its volume was 3.26 million. That was better than the volume of 1.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 31.42%. Additionally, its Average True Range was 0.61.
During the past 100 days, BioXcel Therapeutics Inc’s (BTAI) raw stochastic average was set at 15.73%, which indicates a significant decrease from 20.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 155.91% in the past 14 days, which was higher than the 152.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.38, while its 200-day Moving Average is $14.14. However, in the short run, BioXcel Therapeutics Inc’s stock first resistance to watch stands at $4.14. Second resistance stands at $4.46. The third major resistance level sits at $4.66. If the price goes on to break the first support level at $3.62, it is likely to go to the next support level at $3.42. The third support level lies at $3.10 if the price breaches the second support level.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Key Stats
The company with the Market Capitalisation of 112.10 million has total of 29,273K Shares Outstanding. Its annual sales at the moment are 380 K in contrast with the sum of -165,760 K annual income. Company’s last quarter sales were recorded 460 K and last quarter income was -53,520 K.